Drug intelligence / Profile preview

NerveLight

Development stage
Preclinical
Lead developer
Manzanita Pharmaceuticals
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Administration
Topical, Interstitial
01

Overview

NerveLight (800-rhNGF) is an intraoperative fluorescence imaging agent developed by Manzanita Pharmaceuticals for the real-time visualization of peripheral nerves during oncologic surgeries. It consists of recombinant human Nerve Growth Factor (rhNGF) conjugated to the near-infrared (NIR) dye Dyomics 800. When applied topically or interstitially to the surgical wound bed, the agent binds specifically to Nerve Growth Factor receptors, primarily Tropomyosin receptor kinase A (TrkA), expressed on neural structures. This allows surgeons to identify and preserve critical nerves, such as the cavernous nerves during radical prostatectomy or axillary nerves during breast cancer surgery, thereby reducing the risk of post-operative complications like impotence, urinary incontinence, or sensory loss. The agent is designed to be compatible with the indocyanine green (ICG) channel of existing surgical imaging systems.

Brand names
NerveLight
Other names
Dyomics 800-rhNGFDyomics800-rhNGFDyomics-800-rhNGFdye-conjugated neurotrophin
02

Targets

NTRK1 (Tropomyosin-related receptor kinase A)

Beyond the preview

Go deeper on NerveLight.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NerveLight.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call